Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ICARES Medicus's share price for the quarter that ended in Dec. 2025 was NT$73.9. ICARES Medicus's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 48 Mil. Therefore, ICARES Medicus's market cap for the quarter that ended in Dec. 2025 was NT$3,511 Mil.
ICARES Medicus's quarterly market cap
declined
from Jun. 2025 (NT$5,105 Mil) to Sep. 2025 (NT$4,345 Mil) and
declined
from Sep. 2025 (NT$4,345 Mil) to Dec. 2025 (NT$3,511 Mil).
ICARES Medicus's annual market cap
increased
from Dec. 2023 (NT$4,934 Mil) to Dec. 2024 (NT$5,341 Mil) but then
declined
from Dec. 2024 (NT$5,341 Mil) to Dec. 2025 (NT$3,511 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ICARES Medicus's Enterprise Value for Today is NT$3,801 Mil.
ICARES Medicus (ROCO:6612) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ICARES Medicus Market Cap Related Terms
ICARES Medicus Market Cap Historical Data
* Premium members only.
The historical data trend for ICARES Medicus's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6612 vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, ICARES Medicus's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICARES Medicus Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICARES Medicus's Market Cap distribution charts can be found below:
* The bar in red indicates where ICARES Medicus's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ICARES Medicus's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICARES Medicus (ROCO:6612) has a Market Cap of NT$3,603 Mil as of Jul. 08, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ICARES Medicus and its competitors. According to the industry distribution chart, ICARES Medicus ranks #435 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 50.2%.
Is ICARES Medicus' Market Cap too high?
ICARES Medicus' current Market Cap is NT$3,603 Mil. Based on the distribution chart, ICARES Medicus ranks #435 out of 867 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ICARES Medicus has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ICARES Medicus' Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, ICARES Medicus ranks #435 out of 867 companies for Market Cap. This places ICARES Medicus in the lower half of its industry. The industry median Market Cap is 121.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.11, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ICARES Medicus and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICARES Medicus's current Market Cap is NT$3,603 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICARES Medicus stock overvalued right now?
Based on GuruFocus' analysis, ICARES Medicus (ROCO:6612) is currently considered Possible Value Trap. The stock's GF Value™ is NT$189.52, compared to a current price of NT$76.10 — trading 59.8% below its estimated fair value. The current Market Cap is NT$3,603 Mil. ICARES Medicus' overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For ICARES Medicus (ROCO:6612), the current Market Cap is NT$3,603 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICARES Medicus (ROCO:6612) Overvalued in 2026?
Based on GuruFocus' analysis, ICARES Medicus stock appears to be undervalued.
The current stock price of NT$76.10 is trading 59.8% below its estimated GF Value™ of NT$189.52.
GuruFocus considers ICARES Medicus to be Possible Value Trap.
Key valuation signals for ROCO:6612:
Market Cap: NT$3,603 Mil
GF Value™: NT$189.52 vs. price of NT$76.10 (59.8% below fair value)
No single metric tells the full story. See the ROCO:6612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices. In addition, it also designs, develops, manufactures, and sells intraocular lenses and nanomedical devices. The company's operating segments are Europe and America, which derive maximum revenue, China, and R.O.C. Geographically, it generates maximum revenue from the United States, followed by Taiwan, Spain, England, Japan, China, Germany, and other countries.
84GF Score
Get the complete analysis for ROCO:6612
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6612 has been successfully added to your 
